292 related articles for article (PubMed ID: 34946878)
1. Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?
Tamas T; Baciut M; Nutu A; Bran S; Armencea G; Stoia S; Manea A; Crisan L; Opris H; Onisor F; Baciut G; Crisan B; Opris D; Bumbu B; Tamas A; Dinu C
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946878
[TBL] [Abstract][Full Text] [Related]
2. Non-Melanoma Skin Cancers: Biological and Clinical Features.
Cives M; Mannavola F; Lospalluti L; Sergi MC; Cazzato G; Filoni E; Cavallo F; Giudice G; Stucci LS; Porta C; Tucci M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751327
[TBL] [Abstract][Full Text] [Related]
3. The Role of miRNA-221 and miRNA-34a in Non-Melanoma Skin Cancer of the Head and Neck Region.
Tamas T; Raduly L; Berindan-Neagoe I; Dinu C; Botan E; Bumbu B; Tamas A; Stoia S; Leucuta DC; Bran S; Onisor F; Băciuț G; Armencea G; Băciuț M
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833430
[TBL] [Abstract][Full Text] [Related]
4. [Merkel cell polyomavirus in the pathogenesis of non-melanoma skin cancer].
Zur Hausen A
Pathologe; 2009 Dec; 30 Suppl 2():217-20. PubMed ID: 19921198
[TBL] [Abstract][Full Text] [Related]
5. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA in non-melanoma skin cancer.
Sand M; Sand D; Altmeyer P; Bechara FG
Cancer Biomark; 2012; 11(6):253-7. PubMed ID: 23248183
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
García-Sancha N; Corchado-Cobos R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052530
[TBL] [Abstract][Full Text] [Related]
8. UV-induced skin cancer: similarities--variations.
Boukamp P
J Dtsch Dermatol Ges; 2005 Jul; 3(7):493-503. PubMed ID: 15967008
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA expression in cutaneous squamous cell carcinoma.
Sand M; Bechara FG; Gambichler T; Sand D; Bromba M; Hahn SA; Stockfleth E; Hessam S
J Dermatol Sci; 2016 Sep; 83(3):210-8. PubMed ID: 27298156
[TBL] [Abstract][Full Text] [Related]
10. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
11. miRNAs as Key Players in the Management of Cutaneous Melanoma.
Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer.
Durante G; Broseghini E; Comito F; Naddeo M; Milani M; Salamon I; Campione E; Dika E; Ferracin M
Expert Rev Mol Diagn; 2022 Mar; 22(3):305-318. PubMed ID: 35235479
[TBL] [Abstract][Full Text] [Related]
13. Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma.
Sand M; Hessam S; Amur S; Skrygan M; Bromba M; Stockfleth E; Gambichler T; Bechara FG
J Dermatol Sci; 2017 May; 86(2):142-148. PubMed ID: 28187958
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: Signaling pathway crosstalk.
Rizk NI; Midan HM; Helal GK; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Abdelmaksoud NM; Abdel Mageed SS; Elballal MS; Zaki MB; Abd-Elmawla MA; Al-Noshokaty TM; Elrebehy MA; El-Dakroury WA; Abulsoud LA; Doghish AS
Pathol Res Pract; 2023 Sep; 249():154771. PubMed ID: 37611429
[TBL] [Abstract][Full Text] [Related]
15. A Computational Systems Analyses to Identify Biomarkers and Mechanistic Link in Psoriasis and Cutaneous Squamous Cell Carcinoma.
Adil S; Paracha RZ; Tariq S; Nisar M; Ijaz S; Siddiqa A; Hussain Z; Amir A
Front Immunol; 2021; 12():662528. PubMed ID: 34267747
[TBL] [Abstract][Full Text] [Related]
16. The molecular genetics of eyelid tumors: recent advances and future directions.
Milman T; McCormick SA
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):419-33. PubMed ID: 23275038
[TBL] [Abstract][Full Text] [Related]
17. miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions.
Al-Eryani L; Jenkins SF; States VA; Pan J; Malone JC; Rai SN; Galandiuk S; Giri AK; States JC
PLoS One; 2018; 13(8):e0202579. PubMed ID: 30114287
[TBL] [Abstract][Full Text] [Related]
18. miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma.
Al-Noshokaty TM; Elballal MS; Helal GK; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Abdelmaksoud NM; Abdel Mageed SS; Midan HM; Zaki MB; Abd-Elmawla MA; Rizk NI; Elrebehy MA; Zewail MB; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Sep; 249():154763. PubMed ID: 37595447
[TBL] [Abstract][Full Text] [Related]
19. Dicer cooperates with p53 to suppress DNA damage and skin carcinogenesis in mice.
Lyle S; Hoover K; Colpan C; Zhu Z; Matijasevic Z; Jones SN
PLoS One; 2014; 9(6):e100920. PubMed ID: 24979267
[TBL] [Abstract][Full Text] [Related]
20. The role of miRNAs in cutaneous squamous cell carcinoma.
Yu X; Li Z
J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
